These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 10973321)
1. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nair SK; Heiser A; Boczkowski D; Majumdar A; Naoe M; Lebkowski JS; Vieweg J; Gilboa E Nat Med; 2000 Sep; 6(9):1011-7. PubMed ID: 10973321 [TBL] [Abstract][Full Text] [Related]
2. Immunization with truncated sequence of Telomerase Reverse Transcriptase induces a specific antitumor response in vivo. Qiu J; Li GW; Sui YF; Sun YJ; Huang YY; Si SY; Ge W Acta Oncol; 2007; 46(7):961-8. PubMed ID: 17917827 [TBL] [Abstract][Full Text] [Related]
3. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT. Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991 [TBL] [Abstract][Full Text] [Related]
4. Truncated TERT mRNA transfected dendritic cells evoke TERT specific antitumor response in vivo. Qiu J; Lil GW; Sui YF; Sun YJ; Huang YY; Si SY; Ge W; Song HP Hepatogastroenterology; 2007; 54(75):681-7. PubMed ID: 17591041 [TBL] [Abstract][Full Text] [Related]
5. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide. Okugawa K; Itoh T; Kawashima I; Takesako K; Mazda O; Nukaya I; Yano Y; Yamamoto Y; Yamagishi H; Ueda Y Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491 [TBL] [Abstract][Full Text] [Related]
6. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Strome SE; Voss S; Wilcox R; Wakefield TL; Tamada K; Flies D; Chapoval A; Lu J; Kasperbauer JL; Padley D; Vile R; Gastineau D; Wettstein P; Chen L Cancer Res; 2002 Mar; 62(6):1884-9. PubMed ID: 11912169 [TBL] [Abstract][Full Text] [Related]
7. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer. Kim S; Lee JB; Lee GK; Chang J Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351 [TBL] [Abstract][Full Text] [Related]
8. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells. Boczkowski D; Nair SK; Nam JH; Lyerly HK; Gilboa E Cancer Res; 2000 Feb; 60(4):1028-34. PubMed ID: 10706120 [TBL] [Abstract][Full Text] [Related]
9. Induction of T-cell immunity against Epstein-Barr virus-associated tumors by means of adenovirally transduced dendritic cells. Sun H; Yao K; Chen Y; Zhou F Chin Med J (Engl); 2004 Oct; 117(10):1558-63. PubMed ID: 15498383 [TBL] [Abstract][Full Text] [Related]
10. Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells. Kokhaei P; Palma M; Hansson L; Osterborg A; Mellstedt H; Choudhury A Exp Hematol; 2007 Feb; 35(2):297-304. PubMed ID: 17258078 [TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide. Nishiyama T; Tachibana M; Horiguchi Y; Nakamura K; Ikeda Y; Takesako K; Murai M Clin Cancer Res; 2001 Jan; 7(1):23-31. PubMed ID: 11205913 [TBL] [Abstract][Full Text] [Related]
12. Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients. Danet-Desnoyers GA; Luongo JL; Bonnet DA; Domchek SM; Vonderheide RH Exp Hematol; 2005 Nov; 33(11):1275-80. PubMed ID: 16263411 [TBL] [Abstract][Full Text] [Related]
13. Induction of anti-tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice. Chen L; Tang XD; Yu ST; Ai ZH; Fang DC; Cai YG; Luo YH; Liang GP; Yang SM J Pathol; 2009 Apr; 217(5):685-92. PubMed ID: 19142972 [TBL] [Abstract][Full Text] [Related]
14. Antitumor immunity by a dendritic cell vaccine encoding secondary lymphoid chemokine and tumor lysate on murine prostate cancer. Lu J; Zhang Q; Liang CM; Xia SJ; Zhong CP; Wang DW Asian J Androl; 2008 Nov; 10(6):883-9. PubMed ID: 18958352 [TBL] [Abstract][Full Text] [Related]
15. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells. Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056 [TBL] [Abstract][Full Text] [Related]
16. Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors. Heiser A; Maurice MA; Yancey DR; Coleman DM; Dahm P; Vieweg J Cancer Res; 2001 Apr; 61(8):3388-93. PubMed ID: 11309297 [TBL] [Abstract][Full Text] [Related]
17. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer. Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180 [TBL] [Abstract][Full Text] [Related]
18. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
19. Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer. Mennuni C; Ugel S; Mori F; Cipriani B; Iezzi M; Pannellini T; Lazzaro D; Ciliberto G; La Monica N; Zanovello P; Bronte V; Scarselli E Cancer Res; 2008 Dec; 68(23):9865-74. PubMed ID: 19047167 [TBL] [Abstract][Full Text] [Related]
20. Induction of protective CTL immunity against peptide transporter TAP-deficient tumors through dendritic cell vaccination. Chambers B; Grufman P; Fredriksson V; Andersson K; Roseboom M; Laban S; Camps M; Wolpert EZ; Wiertz EJ; Offringa R; Ljunggren HG; van Hall T Cancer Res; 2007 Sep; 67(18):8450-5. PubMed ID: 17875682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]